Fieldpoint Private Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$30K Sell
62
-47
-43% -$23.3K 0.01% 562
2022
Q1
$54K Sell
109
-2
-2% -$914 0.01% 572
2021
Q4
$51K Buy
111
+10
+10% +$4.21K 0.01% 606
2021
Q3
$38K Buy
101
+37
+58% +$14.1K 0.01% 648
2021
Q2
$24K Hold
64
0.01% 757
2021
Q1
$23K Sell
64
-15
-19% -$4.82K 0.01% 744
2020
Q4
$25K Buy
+79
New +$24.2K 0.01% 628

Other funds holding ELV

Fieldpoint Private Securities's ELV Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Elevance Health (ELV) stake by 43% in Q2 2022, selling an estimated $23.3K and leaving 62 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #562.

Fieldpoint Private Securities first reported a position in ELV in Q4 2020 and has held it in 7 quarters since. The position peaked at $54K in Q1 2022. 1,441 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Fieldpoint Private Securities held 62 shares of Elevance Health worth $30K as of Q2 2022.
  • Fieldpoint Private Securities sold 47 Elevance Health shares in Q2 2022, an estimated $23.3K.
  • Elevance Health made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #562 holding.
  • Fieldpoint Private Securities first reported a position in Elevance Health in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Elevance Health position peaked at $54K in Q1 2022.
  • 1,441 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.